The authors discuss the regulatory role of microRNAs in fine-tuning endoplasmic Reticulum (ER) stress pathways in NSCLC and highlight various promising strategies to overcome chemoresistance by targeting ER stress pathways, offering new therapeutic opportunities.
[Journal of Drug Targeting]